Drugs / Vitis Vinifera Seed Dreid Extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04882228 | Jan 2021 → Feb 2022 | chronic venous insufficiency | Hanlim Pharm. Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vitis Vinifera Seed Dreid Extract | “Vitis Vinifera Seed Dreid Extract 150mg” NCT04882228 ↗ |